Clinical trial

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

NCT00620347

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE2

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2013-06-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

sunitinibDRUG · verified · RxNorm: sunitinib

Sponsors & collaborators

National Cancer Center, Korealead sponsor

Pfizercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00620347 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.